Drug giant Pfizer Inc. is teaming up with San Francisco-based interactive-technology firm Keas Inc. to introduce an onl Read More >>

Pfizer Inc. has named Atrium Staffing of New York City as a primary provider for payrolling services involving independ Read More >>

Pfizer Inc. said today that it is teaming up with San Francisco-based interactive-technology firm Keas Inc. to introduc Read More >>

Pfizer and Keas announced today they have entered into an alliance to collaborate on the Keas platform to enable Health and Wellness experts Read More >>

While Pfizer Inc. is thinning its ranks, drugmaker Bristol-Myers Squibb is taking another tack by freezing salaries and Read More >>

Pfizer, Inc., a US-based biopharmaceutical company, and DxS, Ltd. have entered into an agreement to develop a companion diagnostic t Read More >>

Global healthcare company Pfizer Inc (NYSE: PFE) and DxS, a wholly owned subsidiary of QIAGEN NV (Nasdaq:QGEN) (Xetra: QIA) (Frankfurt: QIA), a provide Read More >>

Pharmaceutical company Pfizer Inc (NYSE:PFE) and DxS, a subsidiary of QIAGEN N.V. (NASDAQ:QGEN) (Frankfurt:QIA), said on Thursday that they have entere Read More >>

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and Read More >>

Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) Read More >>

New York-based pharmaceutical giant Pfizer Inc. is unlikely to continue a bidding war for German generics company Ratio Read More >>

The rally took the day off Wednesday on mixed news: Pfizer (NYSE:PFE) and Ryder (NYSE:R) disappointed and the White House vowed again to overhaul healthcare a Read More >>

Pfizer Inc., whose campuses in Groton and New London employ nearly 5,000 people, reported today a 34 percent increase i Read More >>

The U.S. Food and Drug Administration today gave the go-ahead for the marketing of Xiaflex, the only drug available to Read More >>

Pfizer Inc (PFE)

Expected next earnings release:

Announcement date: 2/3/2010 - Before Market

Earnings Quarter: Q4

Announcement Stat
          
            Read More
            >>
          
        

BUYINS.NET, www.buyins.net, a provider of unique trading technologies, released a report on February 1, 2010 at 9:23 am PST stating that Pfizer (NYSE: PFE) Read More >>

As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechno Read More >>

As Wall Street enters 2010 in the face of a very uncertain economic future, most traders are struggling to consistently profit. With risk Read More >>

(Comment on this article at http://www.financialwire.net/2010/02/03/valuengine-upgrades-loral-space-communications-newmarket-pfizer-constellation-credit- Read More >>

(Comment on this article at http://www.financialwire.net/2010/02/03/conference-calls-today-10-1045-a-m-est-3/)

February 3, 2010 (FinancialWire) ( Read More >>

Pfizer Inc (NYSE: PFE) said it expects 2010 earnings of $2.10 to $2.20 per share on revenue of $67.0 billion to $69.0 billion. The c Read More >>

--Fourth-Quarter 2009 Reported Diluted EPS(1) of $0.10, Adjusted Diluted EPS(2) of $0.49; Full-Year 2009 Reported Diluted EPS(1) of $1.23, Adjusted Diluted Read More >>

INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the ge Read More >>

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Wednesday, February 3rd and determining how th Read More >>

FTC Approves Final Consent Order in Case of Pfizer Inc. and Wyeth

Following a public comment pe Read More >>

BullMarket.com (http://www.bullmarket.com), an online investment newsletter focused on long-term growth and income-generating stocks, has p Read More >>

Research and Markets(http://www.researchandmarkets.com/research/e47fdb/ophthalmic_pharmac) has announced the addition of the "Ophthalmic Pharmaceut Read More >>

Pfizer Inc (PFE)

Expected next earnings release:

Announcement date: 2/3/2010 - Before Market

Earnings Quarter: Q4

Announcement Stat
          
            Read More
            >>
          
        

As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechno Read More >>

Research and Markets (http://www.researchandmarkets.com/research/2db97b/ophthalmic_pharmac) has announced the addition of the "Ophthalmic Pha Read More >>

SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NA Read More >>

Pfizer Inc. has provided an update to its pipeline for the first time since the close of the acquisition of Wyeth in October.

In a release, the C Read More >>

Pfizer Inc.'s antidepressant Zoloft is among the drugs implicated in breastfeeding difficulties some women have after g Read More >>

Pfizer Inc. is thinning out its drug pipeline, but the changes will have no effect on the local employment picture, the Read More >>

Seven Summits Research issues PriceWatch Alerts for BA, PFE, TROW, SYK, and TOL.

Seven Summits Strategic Investments' PriceWatch Alerts are Read More >>

Pfizer Inc. is priming its pipeline.

The pharmaceutical giant, which has major research-and-development sites i Read More >>

BedfordReport.com, www.BedfordReport.com is a free financial portal accessible by all investors. It aims to provide superior content and research Read More >>

Wall Street News Alert's "stocks to watch" this morning are: Spine Pain Management, Inc. (OTCBB: SPIN), Gilead Sciences, Inc. (NASDAQ: GILD), A Read More >>

--Company Meets Key Late-Stage Development Commitments Made to Investors

Pfizer Inc. today provided an update to its pipeline for the first time Read More >>

Pfizer Inc. has announced final results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic neuroendocrine Read More >>

A year after Pfizer Inc. announced its intention to buy Wyeth Pharmaceuticals, Wall Street is going through a honeymoon Read More >>

Stock Market Alerts' performance stock list includes: Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), Poniard Pharmaceuticals, Inc. (N Read More >>

PolyTouch Medical Ltd., a leading developer of hernia mesh placement technologies today announced that it has appointed William (Bill) Read More >>

Pfizer Inc. says its cancer drug Sutent has been shown to extend the lives of people with advanced pancreatic neuroendo Read More >>